|
Osteotech makes no bones about its business -- well, actually, that's exactly what it does. The company uses donated tissue from deceased humans to make bone products for the orthopedic, neurological, oral/maxillofacial, dental, and general surgery markets around the globe. Its Demineralized Bone Matrix (DBM) products, marketed under the Grafton brand name, fill in bone defects and can induce bones to grow. The firm's Base Tissue segment makes weight-bearing structures (Graftech) used in spinal fusion procedures. Additionally, Osteotech processes bovine tissue for use as a substitute for bone grafts. Its products are primarily sold directly to surgeons and hospitals.
|
| | | Contact Information | |
Address: |
51 James Way
Eatontown, NJ 07724
| | Phone: | 732-542-2800 | | Fax: | 732-542-9312 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 103.80 M | | Revenue Growth (1 yr): | (-0.40%) | | Employees (2008): | 331 | | Employee Growth (1 yr): | (-2.10%) |
|
|
Key People
| | • |
Chairman:
Kenneth P. Fallon III
| | • |
President, CEO, and Director:
Sam Owusu-Akyaw
| | • |
EVP Global Operations:
Robert W. Honneffer
|
|
|
